RELEVANT BIOCHEMICAL INDICES OF BLOOD RADIOSENSITIVITY IN GYNECOLOGICAL CANCER PATIENTS
Authors:   R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, Domina E. A. , Makovetska L. I. ,   R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine, Druzhyna M. O. ,   R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine
Published: December 2022

Objective: identification of the relevant biochemical indices of blood radiosensitivity in endometrial cancer patients under the test irradiation in a wide range of doses. Materials and methods. Peripheral blood samples were drawn for assay in the newly diagnosed endometrial cancer patients (study group, n = 42) and healthy donors (control group, n = 27). A set of biochemical values was reviewed to identify and justify the prognostic markers of cell radiosensitivity in the tumor environment featuring gradual development of oxidative stress, namely the intensity of superoxide anion-radical (О2•-) generation, pro-/antioxidant ratio (PAR), and malondialdehyde (MDA) content. Predictive values were selected through the construction and analysis of «dose-response» dependencies of the studied parameters during X-ray test exposure in a dose range of 0.5–3.0 Gy. Nature of the dose curves was determined using linear and linear-quadratic regression models. Results. The 3.2 times higher MDA content was found in blood plasma of endometrial cancer patients compared to the control group, namely (60.87 ± 4.93) μM/g of protein versus (18.93 ± 2.05) μM/g of protein (р ≤ 0.05). The raise in MDA content along with increase in the test radiation dose (in a range of 0.5–3.0 Gy) was approximated by the linear regression model Y = 67.44 + 12.52D, R2 = 0.85. A 1.29–1.74-fold increase in the mean group value depending on the radiation dose was recorded (р ≤ 0.05). Effects of low-dose irradiation (0.5 Gy) were differentiated as (85.03 ± 8.9) against the initial MDA level of (60.87 ± 4.93) μM/g of protein. There was an increase in the intensity of О2•- generation in blood lymphocytes and elevated PAR value in hemolysate from endometrial cancer patients compared to healthy donors by 1.34 and 1.30 times (р ≤ 0.05) respectively, which indicated the intensification of pro-oxidant processes in patients. The inter-individual peculiarities of the blood reaction-response to radiation were revealed according to parameters depending on the initial values, which characterize them only as additional prognostic biomarkers in radiation treatment planning for gynecological cancer patients. Conclusions. It has been proven that the linear nature of dose dependence of MDA content in blood plasma of endometrial cancer patients and response to low-dose irradiation of are the basic criteria for recognizing MDA as a relevant prognostic biochemical indicator of radiosensitivity of healthy cells from the tumor environment. The content of MDA in blood plasma of gynecological cancer patients should be taken into account in order to identify the subjects with a high risk of radiation complications. Key words: cancer patients, peripheral blood, biochemical values, radiosensitivity, dose dependence, radiation complications.